1
2
to trypsin treatment. In this case only a small decrease of
fluorescence was observed by varying pH from 7.4 to 6,
suggesting that the fluorescence detected during the measure-
ment mainly came from internalized nanoconstructs. Flow
cytometry experiments were also conducted in the presence of
propidium iodide (PI) in order to exclude any contribution
of dead cells to fluorescence. Also in this case the addition of
PI did not dramatically alter the initial flow cytometry results
working as a bimodal probe for both confocal laser micro-
scopy and magnetic resonance imaging (MRI) techniques.
Importantly, we expect that the generic nature and versatility
of this approach based on aniline-catalyzed oximation described
in this work will allow any aldehyde-functionalized SPION to
be conjugated to any aminooxyacetyl-derived reagent in a
straightforward manner, using a similar synthetic protocol.
Furthermore, we are planning to investigate the relevance of
this type of bioorthogonal conjugation for in vivo imaging
purposes.
(
ESIw).
Next, confocal microscopy experiments were performed to
confirm the good cellular uptake of nanoconjugate 1a in HeLa
cells and prove the use of such nanodevices for optical micro-
scopy measurements. Cells were incubated for 6 h with
nanoparticles at a final concentration of 1 mM of CF. As
shown in Fig. 1B cells exposed to nanoparticle 1a were
strongly fluorescent (green dots).
We thank M. A. Molins for the help in performing the
HRMAS-NMR measurements and Roger Prades for the
fruitful discussions about the preparation of the MRI samples.
This work was supported by CICYT (CTQ2009-07758 and
2008-00177), ISC III (CB06_01_0074), the Generalitat Catalunya
(2009SGR 1024).
Iron-labeled HeLa cells were studied by MRI in 1% agarose
2
7
phantoms in order to verify if the good cellular uptake
observed by flow cytometry and confocal microscopy could
also give an MRI response. HeLa cells were incubated with
nanoparticle solution 1a at a final concentration of 250 mM of
iron for 4 h, washed, and immobilized in 1% agarose gel. T2
measurements of unlabeled and labeled cells were made using
a multi-slice multi-echo (MSME) sequence on a 7 T MRI
scanner. T2 measured values were 239.1 ms for PBS only,
Notes and references
1
R. K. Jain and T. Stylianopoulos, Nat. Rev. Clin. Oncol., 2010,
, 653.
2 R. Banerjee, Y. Katsenovich, L. Lagos, M. McIintosh, X. Zhang
7
and C.-Z. Li, Curr. Med. Chem., 2010, 17, 3120.
´
C. Carot, P. Robert, J.-M. Idee and M. Port, Adv. Drug Delivery
Rev., 2006, 58, 1471.
J. R. McCarthy, E. Korngold, R. Weissleder and F. A. Jaffer,
Small, 2010, 6, 2041.
3
4
5
6
J. R. McCarthy, Nanomedicine, 2009, 4, 693.
V. I. Shubayev, T. R. Pisanic and S. Jin, Adv. Drug Delivery Rev.,
2
2
36.1 and 134.6 ms for unlabeled and labeled cells, respec-
tively. T2 values were obtained as average values from dupli-
cated determinations (Fig. 1C). This clear decrease in the
T2 value of iron-containing cells demonstrated the utility of
such nanoconjugates for labeling cells for detection by MRI
009, 61, 467.
7 M. Arruebo, R. Ferna
J. Santamarıa, Nano Today, 2007, 2, 22.
´
ndez-Pacheco, M. R. Ibarra and
´
8
M. J. Kogan, I. Olmedo, L. Hosta, A. R. Guerrero, L. J. Cruz and
F. Albericio, Nanomedicine, 2007, 2, 287.
L. LaConte, N. Nitin and G. Bao, Nano Today, 2005, 8, 32.
(
negative contrast).
9
Finally, MTT assay was performed to quantitatively assess
10 M. J. Pittet, F. K. Swirski, F. Reynolds, L. Josephson and
R. Weissleder, Nat. Protoc., 2006, 1, 73.
cell viability. Conjugation of the g-amino-proline-derived
peptide a to SPIONs did not alter the non-toxic profile of
1
1 M. Lewin, N. Carlesso, C.-H. Tung, X.-W. Tang, D. Cory,
D. T. Scadden and R. Weissleder, Nat. Biotechnol., 2000, 18, 410.
the underivatized nanoparticles (SPION-NH
2
) at the same
12 J. Farrera-Sinfreu, E. Giralt, S. Castel, F. Albericio and M. Royo,
J. Am. Chem. Soc, 2005, 127, 9459.
concentration of iron used in the MRI experiments (250 mM),
in contrast TAT–SPION derivate 1b showed some cytotoxicity
13 A. Elmquist and U. Langel, Biol. Chem., 2003, 384, 387.
14 R. Duncan and R. Gaspar, Mol. Pharmaceutics, 2011, 8, 2101.
15 E. M. Sletten and C. R. Bertozzi, Angew. Chem., Int. Ed., 2009,
48, 6974.
(
Fig. 1D). A similar trend was observed in the case of MTT
assay performed incubating HeLa cells with nanoparticles
1
1
1
6 J. A. Prescher and C. R. Bertozzi, Nat. Chem. Biol., 2005, 1, 13.
7 E. H. Cordes and W. P. Jenks, J. Am. Chem. Soc., 1962, 84, 826.
8 A. Dirksen and P. E. Dawson, Bioconjugate Chem. 2008, 19, 2543.
1
a–b at 1 mM concentration of CF (ESIw).
In conclusion, SPIONs with surface benzaldehyde groups
(
SPION-CHO) were prepared and used to conjugate a
19 A. Dirksen, T. M. Hackeng and P. E. Dawson, Angew. Chem., Int. Ed.,
2006, 45, 7581.
g-amino-proline-derived peptide (a). The new CPP–SPION
conjugate 1a was found to have a cell penetrating capability
remarkably higher than that of the TAT–SPION conjugate 1b.
Internalization into HeLa cells was confirmed by confocal
microscopy. Furthermore, the high level of cellular uptake was
demonstrated to provide a decrease in the T2 of labeled cells
relative to control cells. At the concentrations used for cell
labeling, the functionalized nanoparticles were found to be
nontoxic (while some toxicity was found in the case of
analogue TAT–SPION conjugate 1b). To the best of our
knowledge this work represents the first successful example
of the use of aniline-catalyzed oxime chemistry as an efficient
chemoselective type of conjugation of CPPs to SPIONs.
Moreover, the novel CPP–SPION nanoconstruct showed
fluorescent and magnetic properties in just one molecule, thus,
2
2
2
2
0 J. Rayo, N. Amara, P. Krief and M. M. Meijler, J. Am. Chem.
Soc., 2011, 133, 7469.
1 Y. Zeng, T. N. C. Ramya, A. Dirksen, P. E. Dawson and
J. C. Paulson, Nat. Methods, 2009, 6, 207.
2 P. Wu, W. Shui, B. L. Carlson, N. Hu, D. Rabuka, J. Lee and
C. R. Bertozzi, Proc. Natl. Acad. Sci. U. S. A., 2009, 106, 3000.
3 P. A. Venter, A. Dirksen, D. Thomas, M. Manchester,
P. E. Dawson and A. Schneemann, Biomacromolecules, 2011,
12, 2293.
4 E. H. M. Lempens, B. A. Helms, M. Merks and E. W. Meijer,
ChemBioChem, 2009, 10, 658.
5 A. L. Martin, L. M. Bernas, B. K. Rutt, P. J. Foster and
E. R. Gillies, Bioconjugate Chem., 2008, 19, 2375.
6 L. Polito, M. Colombo, D. Monti, S. Melato, E. Caneva and
D. Prosperi, J. Am. Chem. Soc., 2008, 130, 12712.
¨
7 E. Kustermann, U. Himmelreich, K. Kandal, T. Geelen,
A. Ketkar, D. Wiedermann, C. Strecker, J. Esser, S. Arnhold
and M. Hoehn, Contrast Media Mol. Imaging, 2008, 3, 27.
2
2
2
2
5
324 Chem. Commun., 2012, 48, 5322–5324
This journal is c The Royal Society of Chemistry 2012